Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001171843-16-013554

Director acquired 12,345 shares (option exercise)

  • Director gave up 4,403 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

PATOU GARY · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-12-06 Exercise or conversion : show line 1 in the form +12,345 $3.21 $39,627 16,431 D
2016-12-06 Shares withheld for taxes : show line 2 in the form −4,403 $7.90 $34,784 12,028 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-12-06 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −12,345 $3.21 2016-12-31 12,345 0 D
Loading xslF345X03/form4patou.xml…